The case for SS-31, and why it’s part of my protocol
Apr 23, 2026
We spend a lot of time in the Alzheimer’s space talking about amyloid, tau, inflammation, insulin resistance… and all of that matters.
But upstream, there’s a potential failure in the making – one that doesn’t get nearly enough attention.
It starts in the mitochondria.
More specifically, it starts with something called cardiolipin.
Cardiolipin is a specialized fat found almost exclusively in the inner membrane of our mitochondria. It’s not just structural – it’s essential. It holds the entire energy-producing system together. Without it, the machinery that generates ATP begins to falter.
And here’s where it could be relevant – and especially for APOE4 carriers.
As we age, cardiolipin becomes damaged and oxidized. In Alzheimer’s brains, this process is significantly accelerated. The result is a gradual breakdown in mitochondrial efficiency: less energy, more oxidative stress, and increasingly vulnerable neurons.
In other words, before there are plaques… there is an energy problem.
APOE4 appears to amplify this vulnerability. Increased oxidative stress and altered lipid handling make it harder to maintain membrane integrity – including cardiolipin. Over time, this may potentially contribute to the metabolic fragility we see in the APOE4 brain.
So the question becomes:
Can we stabilize the system before damage becomes irreversible?
That’s what led me to SS-31 (Elamipretide).
SS-31 is a small peptide that targets the mitochondria directly. It binds to cardiolipin and helps stabilize the inner membrane, improving efficiency of the electron transport chain and reducing oxidative stress.
It doesn’t address amyloid.
It doesn’t target tau.
It supports something more fundamental: the cell’s ability to produce energy cleanly and efficiently.
In animal models, SS-31 has been shown to:
• Improve mitochondrial function
• Reduce oxidative damage
• Support synaptic health
• Improve cognitive performance
Human data – honestly – is very limited, and this is definitely not a mainstream intervention. But mechanistically, I find it compelling – especially when I’m thinking of ways to maintain my brain until the proverbial “fat lady” sings.
For that reason – and in consideration of my risk that compounds continuously with age (and particularly in the 8th decade of life!) – I decided to incorporate SS-31 into my protocol. Not continuously – but in cycles.
My goal is not constant stimulation, but periodic support – giving mitochondria a chance to repair and reset.
This fits into my broader strategy:
• Maintaining metabolic flexibility
• Supporting mitochondrial biogenesis (exercise)
• Providing membrane building blocks (DHA, phospholipids)
• Reducing oxidative stress
SS-31 is simply one piece of that puzzle.
As always, this is not medical advice – just a reflection of how I’m thinking about prevention, based on current science and personal exploration.
But if there’s one takeaway, it’s this:
We shouldn’t wait for visible pathology to start supporting the systems that keep our neurons alive. And at 73, I certainly don’t have the luxury of time on my side – to wait for science to catch up.
Sometimes the most important interventions are the ones that protect what we can’t see and I’m absolutely willing to take calculated risks when it comes to protecting and preserving the most important part of my body – my brain.
For those interested in diving a little deeper, here is more on the mechanistic picture of SS-31:
1. It stabilizes cardiolipin structure (prevents distortion)
Cardiolipin is uniquely shaped (4 fatty acid tails), which makes it fragile, especially under oxidative stress.
SS-31:
- Inserts itself along cardiolipin-rich regions of the inner mitochondrial membrane
- Prevents cardiolipin from becoming disorganized or “floppy”
2. It protects cardiolipin from peroxidation
Cardiolipin is extremely vulnerable to oxidation (especially its DHA-rich forms).
SS-31:
- Reduces reactive oxygen species (ROS)–induced peroxidation
- Interrupts the cycle where damaged mitochondria → more ROS → more cardiolipin damage
Key effect:
- Preserves functional (non-oxidized) cardiolipin pools
3. It restores electron transport chain supercomplexes
This is one of the most important (and underappreciated) effects.
Cardiolipin is required to assemble:
- Complex I, III, IV into supercomplexes (“respirasomes”)
SS-31:
- Helps cardiolipin maintain the proper curvature and charge environment
- Re-forms and stabilizes these supercomplexes
Result:
- More efficient electron flow
- Less electron “leak” → less ROS
4. It improves cytochrome c function (without triggering apoptosis)
Normally:
- Cardiolipin anchors cytochrome c to the inner membrane
When cardiolipin gets oxidized:
- Cytochrome c detaches → triggers apoptosis cascade
SS-31:
- Maintains cardiolipin in a reduced (healthy) state
- Keeps cytochrome c functionally engaged in energy production, not cell death signaling
Subtle but powerful:
- Supports ATP production
- Reduces inappropriate apoptosis signaling
5. It improves mitochondrial membrane curvature & cristae integrity
Cardiolipin shapes:
- The folds (cristae) inside mitochondria
SS-31:
- Preserves proper membrane curvature
- Prevents cristae collapse or fragmentation
6. It decouples ROS production from ATP generation
In damaged mitochondria:
- ATP production ↓
- ROS ↑
SS-31 helps:
- Restore efficient coupling
- So mitochondria can produce ATP without excessive oxidative spillover
7. It may facilitate cardiolipin remodeling indirectly
Cardiolipin undergoes constant remodeling (via enzymes like tafazzin).
While SS-31 doesn’t directly remodel:
- By protecting cardiolipin from oxidation
- It preserves substrates needed for proper remodeling cycles
Bottom line (what it’s really doing)
SS-31 doesn’t just “bind cardiolipin”, it:
- Preserves its structure
- Prevents its oxidation
- Keeps cytochrome c in energy mode (not death mode)
- Stabilizes mitochondrial ultrastructure
- Restores efficient ATP production